Evidence map›Paper›PMID 31049145›Full record

ReviewMethodist DeBakey cardiovascular journal

How Much Do Lipid Guidelines Help the Clinician? Reading Between the (Guide)lines.

Carl E Orringer

Abstract readReview
In one paragraph

Review in Methodist DeBakey cardiovascular journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Carl E OrringerUNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE, MIAMI, FLORIDA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although lipid guidelines provide updated, practical, and clinically relevant information that may be used in patient care, the continuing publication of new evidence and the inevitable treatment gaps present in all guidelines reinforce the importance of clinical judgment in shared decision making. This article explores the development of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guidelines and the evidence base for managing patients with severe hypercholesterolemia, provides more recent high-quality evidence, and identifies existing treatment gaps that should be considered when caring for such patients. Although it was submitted prior to publication of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol, this review also includes key takeaway messages from the updated guideline.

Indexed as

AdultAgedBiomarkersCardiovascular DiseasesClinical Decision-MakingDyslipidemiasEvidence-Based MedicineFemaleGuideline AdherenceHumansHypolipidemic AgentsLipidsMaleMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'BiomarkersHypolipidemic AgentsLipidsezetimibefamilial hypercholesterolemiahypercholesterolemialipid guidelinesPCSK9 inhibitorsstatins

Identifiers

PMID31049145
PMCPMC6489601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.